JEVTANA (cabazitaxel) is a prescription chemotherapy medication used in the treatment of prostate cancer. Specifically, it is indicated for patients with metastatic hormone-refractory prostate cancer, meaning the cancer has spread to other parts of the body and does not respond to hormonal therapy. JEVTANA works by inhibiting the growth of cancer cells, ultimately leading to their death. It is usually administered in combination with a steroid called prednisone to help manage some of the side effects. As with many chemotherapy drugs, JEVTANA can cause a range of side effects, and its use is carefully monitored by healthcare professionals to ensure the best possible outcome for the patient.